Invert
Data analytics software for biomanufacturing.
San Francisco, United States · Founded 2021
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2021
- Website
- invertbio.com
- Last Round
- SeedJul 2024
- Rounds
- 2
About
We build software to manage, analyze, and optimize bioprocessing data. Our initial customers are bio-industrial companies, who produce various products in bioreactors.
Summary
Invert is an Agtech company based in San Francisco, United States, founded in 2021. Its most recent funding was a Seed round in Jul 2024. Investors include Y Combinator Continuity Fund, Giant Ventures and ACME Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company